tbResList Print — DAS Dasatinib
Filters:
qv=6, qv2=%, rfv=%
Product
DAS Dasatinib
Description:
<b>Dasatinib</b>, (brand name Sprycel) is a targeted therapy medication used to treat certain cases of chronic myelogenous leukemia and acute lymphoblastic leukemia.<br>
Pathway results for Effect on Cancer / Diseased Cells
Total Targets:
0
Pathway results for Effect on Normal Cells
Total Targets:
0
Research papers
Year
Title
Authors
PMID
Link
Flag